874 filings
Page 6 of 44
8-K
ia5xkwqj5oo b2ao
10 Nov 22
Biolase Delivers 26% Revenue Growth Year Over Year In Third Quarter and Raises 2022 Full Year Revenue Guidance
4:09pm
8-K
raf2ba95x
28 Sep 22
Entry into a Material Definitive Agreement
4:29pm
EFFECT
da1cuv6dgkhdcah
25 Aug 22
Notice of effectiveness
12:15am
EFFECT
o0b3haq3f41cihemspd
22 Aug 22
Notice of effectiveness
12:15am
424B3
1n158c4
19 Aug 22
Prospectus supplement
5:05pm
CORRESP
4e325y6s
19 Aug 22
Correspondence with SEC
12:00am
CORRESP
knuh 1v087l1mbk64e0u
17 Aug 22
Correspondence with SEC
12:00am
UPLOAD
ywlunbzr is
17 Aug 22
Letter from SEC
12:00am
UPLOAD
8mgcjqwwchonrnl
15 Aug 22
Letter from SEC
12:00am
8-K
y1zya gu16ehw88ye1l
11 Aug 22
Biolase Delivers 34% Revenue Growth Year Over Year In Second Quarter
4:07pm
8-K
7vfwyf
7 Jul 22
Biolase Enters into Favorable Credit Agreement Amendment
9:35am
8-K
on19 xhnmrjqp6wzz
29 Jun 22
BIOLASE Announces Pricing of $6.5 Million Registered Direct Offering Priced At-the-Market
5:27pm
424B5
65b6j4lue gn
29 Jun 22
Prospectus supplement for primary offering
5:25pm